These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2183934)
1. The role of the blood-brain barrier in movement disorders. Paleologos NA; Groothuis DR Clin Neuropharmacol; 1990 Apr; 13(2):129-46. PubMed ID: 2183934 [TBL] [Abstract][Full Text] [Related]
3. Blood-brain barrier P-glycoprotein function in neurodegenerative disease. Bartels AL Curr Pharm Des; 2011; 17(26):2771-7. PubMed ID: 21831040 [TBL] [Abstract][Full Text] [Related]
4. Effect of movement frequency on repetitive finger movements in patients with Parkinson's disease. Espay AJ; Lang AE; Chen R Mov Disord; 2010 Jan; 25(2):252; author reply 253. PubMed ID: 20063321 [No Abstract] [Full Text] [Related]
5. The role of the subthalamic nucleus in the origin of hemiballism and parkinsonism: new surgical perspectives. Guridi J; Obeso JA Adv Neurol; 1997; 74():235-47. PubMed ID: 9348418 [No Abstract] [Full Text] [Related]
6. Three types of akinesia in the progressive course of Parkinson's disease. Narabayashi H Adv Neurol; 1993; 60():18-24. PubMed ID: 8093577 [No Abstract] [Full Text] [Related]
7. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats. Miyazaki S; Yanagida T; Nunome K; Ishikawa S; Inden M; Kitamura Y; Nakagawa S; Taira T; Hirota K; Niwa M; Iguchi-Ariga SM; Ariga H J Neurochem; 2008 Jun; 105(6):2418-34. PubMed ID: 18373560 [TBL] [Abstract][Full Text] [Related]
11. Neural disorders of the linguistic use of space and movement. Poizner H; Kegl J Ann N Y Acad Sci; 1993 Jun; 682():192-213. PubMed ID: 8323113 [No Abstract] [Full Text] [Related]
12. Where and what is the PPN and what is its role in locomotion? Windels F; Thevathasan W; Silburn P; Sah P Brain; 2015 May; 138(Pt 5):1133-4. PubMed ID: 25907754 [TBL] [Abstract][Full Text] [Related]
13. Transcranial magnetic stimulation in movement disorders. Berardelli A Electroencephalogr Clin Neurophysiol Suppl; 1999; 51():276-80. PubMed ID: 10590960 [No Abstract] [Full Text] [Related]
14. [The measurement of kinetic energy in movement accomplishment]. Birkmayer W Wien Med Wochenschr; 1967 Dec; 117(50):1138-9. PubMed ID: 5596102 [No Abstract] [Full Text] [Related]
15. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. Tsuji A NeuroRx; 2005 Jan; 2(1):54-62. PubMed ID: 15717057 [TBL] [Abstract][Full Text] [Related]
16. Movement disorders in the elderly. Gilmore R Geriatrics; 1984 Jun; 39(6):65-8, 72-6. PubMed ID: 6144615 [No Abstract] [Full Text] [Related]
17. [Designing drugs for transport into the brain]. Borisoba NV; Kaplun AP; Shvets VI Vopr Med Khim; 1998; 44(5):437-51. PubMed ID: 9916259 [TBL] [Abstract][Full Text] [Related]
18. In vitro models for the blood-brain barrier. Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540 [TBL] [Abstract][Full Text] [Related]